BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Santaris Pharma A/S (Formerly Pantheco A/S) 

Danish Science Park
Bøge Alle 3
Hørsholm    DK 2970  Denmark
Phone: 45-4517-9800 Fax: 45-4517-9898


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/4/2014 9:52:10 AM
Danish Drug Maker Santaris Pharma A/S Considers U.S. Listing 3/27/2014 7:18:12 AM
Santaris Pharma A/S, Roche (RHHBY) Strike $148 Million+ Alliance To Design And Develop RNA-Targeted Drugs 1/10/2014 7:34:21 AM
Santaris Pharma A/S, GlaxoSmithKline (GSK) Forges Pact To Develop RNA-Targeted Medicines, Financial Details Not Disclosed 1/10/2014 7:03:37 AM
Isarna Therapeutics And Santaris Pharma A/S Announce License Agreement For The Development Of Next Generation Oligonucleotides To Treat TGF-Beta-Mediated Diseases 1/8/2014 9:52:47 AM
Santaris Pharma A/S Announces Appointment Of J. Donald Debethizy As President And Chief Executive Officer 1/8/2014 8:13:54 AM
Santaris Pharma A/S Resumes Full Ownership of Cancer Programs Licensed to Enzon Pharmaceuticals, Inc. (ENZN) 10/28/2013 10:21:35 AM
Shire plc and Shire Pharmaceuticals (SHPG) Extends Existing Rare Genetic Disease Pact 8/23/2013 7:09:38 AM
RaNA Therapeutics, Inc. and Santaris Pharma A/S Announce Agreement to develop RNA-Targeted Medicines That Selectively Activate Protein Expression 7/8/2013 10:16:23 AM
Santaris Pharma A/S Release: EPO Appeal Board Decides in Favor of the Wengel LNA Patent 4/18/2013 9:51:27 AM
1234567